Pricing Log in Create free account
Friday 6 November 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

KRYS Healthcare Biotechnology

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.

Revenue
+30.2%
EPS
−22.3%
Free cash flow
+137.8%

Quarter to September 2026, against a year earlier

301.84 1.59 +0.53%
Market cap
$8.9B
P/E
39.2×
Fwd P/E
45.7×
Dividend yield
—
F-score
7/9
Altman Z
39.03
Beneish M
−2.27
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Krystal Biotech, Inc. (KRYS) Current ratio

Alert me on Current ratio

Krystal Biotech, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 7.9×, down 2.1× from fiscal 2025 (10.0×). Over the past ten years it has ranged from 7.3× (fiscal 2024) to 78.0× (fiscal 2017); the current reading is higher than 20% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 10.0× 36.81%
FY2024 7.3× (59.05%)
FY2023 17.8× 33.53%
FY2022 13.3× (22.58%)
FY2021 17.2× (3.46%)
FY2020 17.8× (69.77%)
FY2019 58.9× 35.68%
FY2018 43.4× (44.36%)
FY2017 78.0× 54.61%
FY2016 50.4× —

Quarterly newest first

Period Current ratio Change
Sep 2026 7.9× (5.12%)
Jun 2026 8.3× (12.07%)
Mar 2026 9.5× (4.96%)
Dec 2025 10.0× (1.86%)
33 more quarters

Against its own ten years

Low 7.3× High 78.0×
Ten-year median 17.8×
Current reading's percentile 20

Current ratio against peers

Company Current ratio
SYRE Spyre Therapeutics, Inc. compare 27.4×
PTGX Protagonist Therapeutics, Inc. compare 21.7×
KRYS Krystal Biotech, Inc. 7.9×
CAI Caris Life Sciences,�Inc. compare 6.7×
IBRX ImmunityBio, Inc. compare 5.7×
TGTX TG Therapeutics, Inc. compare 4.3×
CYTK Cytokinetics, Incorporated compare 3.4×
MDGL Madrigal Pharmaceuticals, Inc. compare 3.1×
TWST Twist Bioscience Corporation compare 2.7×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on KRYS